AMINOSYN II 10% W/ ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
NDAINJECTIONINJECTABLE
Approved
Apr 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN II 10% W/ ELECTROLYTES is an intravenous amino acid solution with essential electrolytes (magnesium, potassium, sodium, phosphate) designed for parenteral nutrition support. It provides nitrogen and electrolyte replenishment in patients unable to receive adequate nutrition orally or enterally. The formulation supplies balanced amino acids and critical minerals to maintain protein synthesis and electrolyte homeostasis.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%), signaling potential team consolidation and shift toward managed care and hospital contracting roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMINOSYN II offers stability in a mature, essential-use category with consistent hospital demand, but limited growth trajectory and innovation exposure. Career advancement depends on excelling in contracting, hospital relationships, cost management, and operational excellence rather than breakthrough science or market expansion.
Hospital Account ManagerContracting Specialist
Worked on AMINOSYN II 10% W/ ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.